Affordable GLP-1 Solutions for Self-Insured Companies

Affordable GLP-1 Solutions for Self-Insured Companies

Save up to 80% on GLP-1 costs with MyStart’s Compounded Medications while improving employee wellness and reducing long-term healthcare expenses.

The Rising Cost Crisis of GLP-1 Medications

Self-insured companies are facing an unprecedented challenge: the skyrocketing costs of brand-name GLP-1 medications like Ozempic and Wegovy. These drugs, while highly effective for weight loss and diabetes management, can cost over $1,000 per month per employee—a price tag that is unsustainable for many organizations.

Real-World Examples of the Cost Burden

University of Texas System

GLP-1 costs tripled to $5 million per month, forcing the system to discontinue coverage for weight loss drugs like Wegovy and Saxenda.

Ascension

This healthcare system, with nearly 140,000 employees, halted coverage for weight loss medications due to unsustainable expenses.

Blue Cross Blue Shield of Michigan

GLP-1 costs surged by $350 million from 2022 to 2023, leading to coverage restrictions for self-insured plans.

* These examples highlight a critical issue: brand-name GLP-1 medications are pricing themselves out of reach, threatening both employee health benefits and corporate budgets.

Monthly Cost Comparison: Brand-name vs. MyStart Compounded GLP-1s.

"Switching to MyStart’s compounded GLP-1s saved our company over $1 million in the first year while helping our employees lose an average of 12 pounds."

- Luka Isakovic CFO @ Mid-Sized Manufacturing Firm

Why Compounded GLP-1 Medications Are the Solution

Compounded GLP-1 medications, custom-formulated by FDA-regulated pharmacies, offer the same health benefits as brand-name drugs at a fraction of the cost. MyStartHealth.com provides these high-quality alternatives starting at just $230 per employee per month.

Affordability
Save up to 80% compared to brand-name GLP-1s.
Quality Assurance
Sourced from FDA-regulated compounding pharmacies to ensure safety and efficacy.
Flexibility
Address shortages and provide consistent access to medications for your employees.

The Long-Term Payoff - Healthier Employees, Stronger Savings

Obesity is a leading driver of healthcare costs, contributing to $147 billion annually in U.S. medical expenses for conditions like diabetes, heart disease, and hypertension. By providing affordable access to GLP-1 medications, MyStart helps self-insured companies tackle obesity head-on, reducing long-term healthcare costs and improving employee productivity.

Health and Economic Benefits

1) Clinical Outcomes:

• GLP-1s facilitate 5–25% weight loss, reducing the risk of chronic diseases.
• A 10% reduction in body weight can lower diabetes risk by 50% (American Diabetes Association).

2) Cost Savings:

• Obesity-related claims cost employers $8,000 per obese employee annually (Journal of Occupational and Environmental Medicine).
• GLP-1s can offset initial costs within 2–3 years by reducing chronic disease management expenses (Health Affairs study).

Why Choose MyStartHealth.com?

MyStartHealth.com is your trusted partner in delivering affordable, high-quality GLP-1 solutions tailored to the needs of self-insured companies.

like-button-black

Cost Savings: Starting at $230 per employee per month, our compounded GLP-1s offer up to 80% savings.

like-button-black

Customized Programs: We design plans based on your workforce’s health data to maximize impact.

like-button-black

Proven Results: Clients report 12% average weight loss and millions in annual savings.

Demonstrate cumulative savings from switching to MyStart’s GLP-1s

Take Action - Contact MyStart Health Today

The evidence is clear: brand-name GLP-1 medications are financially unsustainable for self-insured companies, but affordable alternatives exist. MyStartHealth.com’s compounded GLP-1 solutions deliver the same health benefits at a fraction of the cost, offering immediate savings and long-term value.